ZNF77 | Zinc finger protein 77 | Transcription factors
| | | | | Mixed |
TLE6 | Transducin-like enhancer of split 6 (E(sp1) homolog, Drosophila) | | | | | | Mixed |
TLE2 | Transducin-like enhancer of split 2 (E(sp1) homolog, Drosophila) | | | | | | Expressed in all |
AES | Amino-terminal enhancer of split | | | | | | Expressed in all |
GNA11 | Guanine nucleotide binding protein (G protein), alpha 11 (Gq class) | Cancer-related genes Disease related genes
| | | | | Expressed in all |
GNA15 | Guanine nucleotide binding protein (G protein), alpha 15 (Gq class) | Plasma proteins
| | | | | Tissue enhanced |
S1PR4 | Sphingosine-1-phosphate receptor 4 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
NCLN | Nicalin | Predicted membrane proteins
| | | | | Expressed in all |
CELF5 | CUGBP, Elav-like family member 5 | | | | | | Tissue enriched |
NFIC | Nuclear factor I/C (CCAAT-binding transcription factor) | Transcription factors
| | | | | Expressed in all |
C19orf77 | Chromosome 19 open reading frame 77 | Predicted membrane proteins
| | | | | Tissue enhanced |
DOHH | Deoxyhypusine hydroxylase/monooxygenase | Enzymes
| | | | | Mixed |
FZR1 | Fizzy/cell division cycle 20 related 1 (Drosophila) | | | | | | Expressed in all |
MFSD12 | Major facilitator superfamily domain containing 12 | Predicted membrane proteins
| | | | | Expressed in all |
C19orf71 | Chromosome 19 open reading frame 71 | | | | | | Tissue enhanced |
HMG20B | High mobility group 20B | Transcription factors
| | | | | Expressed in all |
GIPC3 | GIPC PDZ domain containing family, member 3 | Disease related genes
| | | | | Mixed |
TBXA2R | Thromboxane A2 receptor | Disease related genes FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Mixed |
CACTIN | Cactin, spliceosome C complex subunit | | | | | | Expressed in all |
PIP5K1C | Phosphatidylinositol-4-phosphate 5-kinase, type I, gamma | Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
TJP3 | Tight junction protein 3 | | | | | | Mixed |
APBA3 | Amyloid beta (A4) precursor protein-binding, family A, member 3 | | | | | | Expressed in all |
MRPL54 | Mitochondrial ribosomal protein L54 | Mitochondrial proteins
| | | | | Expressed in all |
RAX2 | Retina and anterior neural fold homeobox 2 | Disease related genes Transcription factors
| | | | | Not detected |
MATK | Megakaryocyte-associated tyrosine kinase | Cancer-related genes Enzymes
| | | | | Mixed |
ZFR2 | Zinc finger RNA binding protein 2 | | | | | | Group enriched |
ATCAY | Ataxia, cerebellar, Cayman type | Disease related genes
| | | | | Tissue enriched |
NMRK2 | Nicotinamide riboside kinase 2 | Enzymes
| | | | | Group enriched |
DAPK3 | Death-associated protein kinase 3 | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
EEF2 | Eukaryotic translation elongation factor 2 | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
PIAS4 | Protein inhibitor of activated STAT, 4 | | | | | | Expressed in all |
AC016586.1 | | Predicted secreted proteins
| | | | | Not detected |
ZBTB7A | Zinc finger and BTB domain containing 7A | Transcription factors
| | | | | Expressed in all |
MAP2K2 | Mitogen-activated protein kinase kinase 2 | Cancer-related genes Disease related genes Enzymes FDA approved drug targets RAS pathway related proteins
| | | | | Expressed in all |
CREB3L3 | CAMP responsive element binding protein 3-like 3 | Predicted membrane proteins Transcription factors
| | | | | Group enriched |
SIRT6 | Sirtuin 6 | | | | | | Expressed in all |
ANKRD24 | Ankyrin repeat domain 24 | | | | | | Tissue enhanced |
EBI3 | Epstein-Barr virus induced 3 | Predicted secreted proteins
| | | | | Tissue enriched |
CCDC94 | Coiled-coil domain containing 94 | | | | | | Expressed in all |
SHD | Src homology 2 domain containing transforming protein D | | | | | | Group enriched |
TMIGD2 | Transmembrane and immunoglobulin domain containing 2 | Predicted membrane proteins
| | | | | Tissue enhanced |
FSD1 | Fibronectin type III and SPRY domain containing 1 | | | | | | Tissue enhanced |
STAP2 | Signal transducing adaptor family member 2 | | | | | | Mixed |
MPND | MPN domain containing | Enzymes
| | | | | Expressed in all |
SH3GL1 | SH3-domain GRB2-like 1 | Cancer-related genes Disease related genes
| | | | | Expressed in all |
CHAF1A | Chromatin assembly factor 1, subunit A (p150) | | | | | | Expressed in all |
UBXN6 | UBX domain protein 6 | Plasma proteins
| | | | | Expressed in all |
HDGFRP2 | Hepatoma-derived growth factor-related protein 2 | | | | | | Expressed in all |
PLIN4 | Perilipin 4 | Plasma proteins
| | | | | Tissue enriched |
PLIN5 | Perilipin 5 | Predicted membrane proteins
| | | | | Tissue enhanced |